medigraphic.com
ISSN 1561-3046 (Electronic)

2013, Number 2

<< Back Next >>

Rev Cub Med Mil 2013; 42 (2)

Characterization of patients with diabetic foot

Rodríguez GD, González EA

Language: Spanish
References: 18
Page: 173-180
PDF size: 118.30 Kb.


ABSTRACT

Introduction: diabetic foot is considered a health problem worldwide because of the high number of admissions to hospital services.
Objective: to characterize patients with diabetic foot.
Methods: a descriptive retrospective study was conducted during a period of 15 months in those cases who were admitted to the Department of Angiology and Vascular Surgery of the Military Hospital of Holguín with a diagnosis of diabetic foot according to Wagner classification.
Results: diabetic foot represented the 53 % of the total of admissions in the service; the average age of patients was 64,8 years; a predominance among 51 and 60 years of age was observed and more often in grades 1 and 2 of Wagner classification, with 25 patients in each ones. Neuroinfectious diabetic foot, according to the classification by Mc Cook was highlighted, representing a 38,35 % of the total. 41 operations were performed; about half of them were necrotomies with a poor use of vascular surgical procedures.
Conclusions: patients were characterized as being between 51 and 60 years, with Type 2 diabetes on admission, smokers, hypertensive and suffering from hypercholesterolemia. There was a tendency to perform conservative operations.


REFERENCES

  1. La diabetes en las Américas. Boletín Epidemiológico de la Organización Panamericana de la Salud. 2001;2(2):1-3.

  2. Rivero FFE, Vejerano GPP, Conde PPR, Socarrás ONF, Otero RM, Expósito MT, et al. Resultado de un modelo de atención preventiva del pie diabético en la comunidad [Internet]. Buenos Aires: Sociedad Iberoamericana de Información Científica (SIIC). 2004. [citado 25 May 2007]. Disponible en: http://www.siicsalud.com/des/des040/04026014.htm

  3. Martínez LR. Qué es el pie. En: Martínez LR. Manual del pie diabético. Cartago: E T de Costa Rica; 2006. p. 9-32.

  4. Valdés S, Rojo-Martínez G, Soriguer F. Evolución de la prevalencia de la diabetes tipo 2 en población adulta española. Med Clín. 2007;129:352-55.

  5. Fernández Montequin J, Sancho Soutelo N, Fleitas Pérez E, Santiesteban Bonaechea Ll. El Heberprot-P como indicación terapéutica en el tratamiento curativo de las úlceras por presión. Rev Esp Inv Quir [Internet] 2011 [citado 25 May 2007];43:143-5. Disponible en: http://dialnet.unirioja.es/servlet/articulo?codigo=3731870

  6. Fernández Montequin J, Mena G, Santiesteban Ll. Tratamiento y recuperación del pie diabético grado 5 de la clasificación de Wagner tras aplicar el Heberprot-P. Biotecnol [Internet] 2010 Abr-Jun [citado 12 Jun 2012];27(2). Disponible en: http://scielo.sld.cu/scielo.php?pid=S1027- 28522010000200005&script=sci_arttext&tlng=pt

  7. Fernández Montequin J, Mena G, Santiesteban Bonaechea Ll. El heberprot p es una alternativa eficaz en el tratamiento del pie diabético grado 5 de la clasificación de Wagner. Rev Esp Inv Quir [Internet] 2009 [citado 12 Jun 2012];XII(4):165-8. Disponible en: http://www.reiq.es/REIQ12.4.2009.pdf#page=23

  8. Fernández Montequin J, Mena G, Santiesteban Bonaechea Ll. El heberprot p es una alternativa eficaz en el tratamiento del pie diabético grado 5 de la clasificación de Wagner. Rev Esp Inv Quir [Internet] 2009. [citado 12 Jun 2012];XII(4);165-168. Disponible en: http://dialnet.unirioja.es/servlet/ejemplar?clave_revista=13562&clave_ejemplar=239 116&info=open_link_ejemplar#page=23

  9. Ruiz-Ramos R, Escolar-Pujolar A, Mayoral-Sánchez E, Corral-San Laureano F, Fernández-Fernández I. La diabetes mellitus en España: mortalidad, prevalencia, incidencia, costes económicos y desigualdades. Gaceta Sanitaria. 2006;20(Supl 1):15-24.

  10. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet 2005;366:1719-24.

  11. Anichini R, Zecchini F, Cerretini I, Meucci G, Fusilli D, Alviggi L. Improvement of diabetic foot care after the Implementation of the International Consensus on the Diabetic Foot (ICDF): results of a 5-year prospective study. Diabetes Res Clin Pract. 2007;75:153-8.

  12. Malay DS, Margolis DJ, Hoffstad OJ, Bellamy S. The incidence and risks of failure to heal after lower extremity amputation for the treatment of diabetic neuropathic foot ulcer. J Foot Ankle Surg. 2006;45:366-74.

  13. Marinello RJ, Blanes MJL, Escudero RJR, Ibáñez EV, Rodríguez OJ. Tratado de pie diabético. Madrid: Jarpyo; 2002. p. 86-167.

  14. Mc Cook MJ, Montalvo DJ. Ariosa CM, Fernández HP. Hacia una clasificación etiopatogénica del llamado pie diabético. Angiología. 1979;31:9-11.

  15. González A. Morbilidad por el síndrome de pie diabético. Rev Cubana Angiol Cir Vasc [Internet] 2003 [citado 12 Jun 2012];4(1). Disponible en: http://bvs.sld.cu/revistas/ang/vol4_1_03/ang06103.htm

  16. Shojaiefard A, Khorgami Z, Larijani B. Septic diabetic foot is not necessarily an indication for amputation. J Foot Ankle Surg. 2008 Sep-Oct;47(5):419-23.

  17. Clavel S. Is amputation for the diabetic foot inevitable? Soins. 2008 Apr(724 Suppl):S25-7.

  18. Got I. Necessary multidisciplinary management of diabetic foot. J Mal Vasc. 2007;26(2):130-4.




2020     |     www.medigraphic.com